Cancer vaccines (Part 2 of 2)

P. A. Hallin, V. R. Adams

Research output: Contribution to journalShort surveypeer-review

Original languageEnglish
Pages (from-to)706-709
Number of pages4
JournalJournal of the American Pharmaceutical Association (Washington,D.C. : 1996)
Issue number6
StatePublished - 1997

Bibliographical note

Funding Information:
is developed by the Ameri can Pharmaceutical Asso ciation, edited by Peggy Piascik, PhD, University of Kentucky College of Pharmacy, and supported by an educational grant from Amgen Inc. The views expressed are not neces sarily those of Amgen.

ASJC Scopus subject areas

  • Pharmaceutical Science


Dive into the research topics of 'Cancer vaccines (Part 2 of 2)'. Together they form a unique fingerprint.

Cite this